As a leader in the field of Inhalation, DFE pharma offers the pharmaceutical industry the most optimal solution for the development of their Dry Powder Inhalation (DPI) drug. DFE pharma is a partner for pharmaceutical companies developing drugs for pulmonary delivery for many years. We offer a wide range of standard products, plus the option to customize our products to meet your specific needs.
Most medicines, from over the counter treatments to prescription drugs, are taken by mouth in the form of tablets and capsules. Oral medicines are convenient, flexible and cost-effective. They can be produced in large numbers very fast (production rates of 1 million per hour can be achieved). Variants that are precisely suited to individual preferences and needs can easily be developed.
We develop, produce and supply excipients for use in oral solid dose and dry powder inhalation, but as a supplier of complete solutions we do a lot more than that. We work closely with pharmaceutical companies around the world, collaborating in original research, supporting their go to market strategies and fine-tuning our products to ensure that their medicines deliver exactly the right outcomes for patients.
That makes us more than just a supplier. We are recognised as a true partner to the pharmaceutical industry in helping people round the world lead healthier lives.
We have spent more than 100 years in proving that excellence is not just a word but a deep, long-term commitment to our customers and to the millions of patients who use our products every day. Our customers respect us for product quality, technical expertise and hands-on market support. We work with your future in mind: today, tomorrow and always.
Our portfolio consists of filler/binders (Lactose, Microcrystalline Cellulose, Starches), superdisintegrants (Croscarmellose Sodium and Sodium Starch Glycolate) for oral solid dose and carriers for inhalation (Lactose).
